Skip to Main Content


Michael Kozal, MD

Professor Adjunct; Chief of Staff, VA Palo Alto Healthcare System

Contact Information

Michael Kozal, MD

Research Summary

Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and is a current member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents.

Specialized Terms: Genetic determinants of HIV and Hepatitis C drug resistance; New technologies to detect low abundance drug resistant viral variants


Research Interests

Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Drug Resistance; Hepatitis C; HIV; Veterans; Infectious Disease Medicine

Selected Publications